-
公开(公告)号:AU697681B2
公开(公告)日:1998-10-15
申请号:AU2856097
申请日:1997-07-09
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING LEUNG , ZHAO CHEN , SOWIN THOMAS J , RENO DANIEL S , HAIGHT ANTHONY R , COOPER ARTHUR J
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.
-
公开(公告)号:DK0674513T3
公开(公告)日:1997-03-17
申请号:DK94905429
申请日:1993-12-16
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING LEUNG , ZHAO CHEN , SOWIN THOMAS J , RENO DANIEL S , HAIGHT ANTHONY R , COOPER ARTHUR J
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.
-
公开(公告)号:GR3021170T3
公开(公告)日:1996-12-31
申请号:GR960402518
申请日:1996-09-26
Applicant: ABBOTT LAB
Inventor: KEMPF DALE J , NORBECK DANIEL W , SHAM HING LEUNG , ZHAO CHEN , SOWIN THOMAS J , RENO DANIEL S , HAIGHT ANTHONY R , COOPER ARTHUR J
IPC: C07D275/02 , A61K31/395 , A61K31/415 , A61K31/4164 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K38/00 , A61K45/06 , A61P31/12 , A61P31/18 , A61P35/00 , A61P35/02 , A61P37/04 , A61P43/00 , C07C33/46 , C07C43/164 , C07C43/174 , C07C43/205 , C07C43/215 , C07C43/23 , C07C43/30 , C07C43/315 , C07C45/00 , C07C45/29 , C07C45/56 , C07C45/62 , C07C45/67 , C07C45/74 , C07C53/134 , C07C69/34 , C07C69/65 , C07C69/732 , C07C211/27 , C07C215/18 , C07C215/20 , C07C215/28 , C07C229/08 , C07C229/26 , C07C229/34 , C07C233/36 , C07C233/40 , C07C235/10 , C07C235/12 , C07C235/34 , C07C235/78 , C07C237/10 , C07C237/20 , C07C237/22 , C07C239/10 , C07C239/18 , C07C239/20 , C07C247/10 , C07C251/40 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/16 , C07C275/24 , C07C311/03 , C07C311/13 , C07C311/18 , C07C317/10 , C07C317/28 , C07C317/44 , C07C323/12 , C07C323/25 , C07C381/00 , C07D20060101 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D233/54 , C07D233/84 , C07D235/10 , C07D235/14 , C07D235/16 , C07D239/26 , C07D241/12 , C07D261/06 , C07D261/08 , C07D263/24 , C07D263/30 , C07D263/32 , C07D263/48 , C07D265/30 , C07D277/22 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/42 , C07D333/16 , C07D401/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D521/00 , C07F5/02 , C07F5/04 , C07K5/06 , C07K5/065
Abstract: A retroviral protease inhibiting compound of formula (A) is disclosed for use in combination with other active pharmaceutical agents for treating a human infected by HIV. Intermediates and processes useful in the manufacture of compounds of formula (A) are also disclosed.
-
公开(公告)号:AU3150395A
公开(公告)日:1996-03-07
申请号:AU3150395
申请日:1995-07-26
Applicant: ABBOTT LAB
Inventor: ZHAO CHEN , KEMPF DALE J , SHAM HING L , NORBECK DANIEL W , BETEBENNER DAVID A , LIN SHUQUN
IPC: C07C281/02 , C07D255/02 , C07D405/06 , C07D405/14 , C07D413/14 , C07D417/14 , A61K31/55 , C07D295/08 , C07D403/06 , C07D413/06 , C07D417/06 , C07F7/08
-
公开(公告)号:AU650491B2
公开(公告)日:1994-06-23
申请号:AU8771591
申请日:1991-11-08
Applicant: ABBOTT LAB
Inventor: KEMPF DALE , CODACOVI LYNN M , SHAM HING L , WITTENBERGER STEVEN J , NORBECK DANIEL W , PLATTNER JACOB J , ZHAO CHEN , SOWIN THOMAS J
IPC: A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/435 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K38/00 , A61P31/12 , A61P31/18 , A61P43/00 , C07C53/134 , C07C211/00 , C07C215/18 , C07C215/20 , C07C215/28 , C07C215/30 , C07C215/80 , C07C219/18 , C07C233/40 , C07C237/10 , C07C237/22 , C07C269/04 , C07C271/02 , C07C271/16 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/24 , C07D20060101 , C07D213/00 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/36 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D213/79 , C07D215/20 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D237/10 , C07D239/26 , C07D241/12 , C07D261/08 , C07D261/12 , C07D263/20 , C07D263/32 , C07D277/20 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/02 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/34 , C07D307/42 , C07D307/66 , C07D333/16 , C07D333/36 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/08 , C07K14/81 , C07D213/70 , C07D213/74 , C07D213/32 , C07D295/135 , C07D491/048 , C07D277/48 , C07D233/16 , C07D233/42 , C07D307/12 , C07D231/12 , C07D307/28 , C07D305/06 , C07C233/36 , C07C271/52 , C07C233/38 , C07K5/02 , A61K37/64
Abstract: An intermediate of the formula: and an intermediate of the formula: or an acid addition salt thereof.M
-
公开(公告)号:PT99545A
公开(公告)日:1992-09-30
申请号:PT9954591
申请日:1991-11-19
Applicant: ABBOTT LAB
Inventor: SHAM HING L , PLATTNER JACOB J , NORBECK DANIEL W , KEMPF DALE J , CODACOVI LYNN M , WITTENBERGER STEVEN J , ZHAO CHEN
IPC: A61K31/42 , A61K31/421 , A61K31/425 , A61K31/426 , A61K31/427 , A61K31/435 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K38/00 , A61P31/12 , A61P31/18 , A61P43/00 , C07C53/134 , C07C211/00 , C07C215/18 , C07C215/20 , C07C215/28 , C07C215/30 , C07C215/80 , C07C219/18 , C07C233/40 , C07C237/10 , C07C237/22 , C07C269/04 , C07C271/02 , C07C271/16 , C07C271/20 , C07C271/22 , C07C271/34 , C07C275/24 , C07D20060101 , C07D213/00 , C07D213/26 , C07D213/30 , C07D213/34 , C07D213/36 , C07D213/40 , C07D213/54 , C07D213/56 , C07D213/61 , C07D213/75 , C07D213/79 , C07D215/20 , C07D233/54 , C07D233/84 , C07D235/14 , C07D235/16 , C07D237/10 , C07D239/26 , C07D241/12 , C07D261/08 , C07D261/12 , C07D263/20 , C07D263/32 , C07D277/20 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/32 , C07D277/34 , C07D277/36 , C07D277/40 , C07D277/42 , C07D277/56 , C07D295/02 , C07D295/13 , C07D295/205 , C07D295/215 , C07D303/36 , C07D307/34 , C07D307/42 , C07D307/66 , C07D333/16 , C07D333/36 , C07D401/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07D471/04 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/08 , C07K14/81 , C07C , C07D , A61K
Abstract: An intermediate of the formula: and an intermediate of the formula: or an acid addition salt thereof.M
-
公开(公告)号:ES2426965T3
公开(公告)日:2013-10-28
申请号:ES10176829
申请日:2004-11-10
Applicant: ABBOTT LAB , ABBVIE INC
Inventor: FLENTGE CHARLES A , CHEN HUI-JU , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , MADIGAN DAROLD L , RANDOLPH JOHN T , SUN MINGHUA , YEUNG MING C , ZHAO CHEN
IPC: C07D417/06 , A61K31/175 , A61K31/18 , A61K31/195 , A61K31/277 , A61K31/4166 , A61K31/4168 , A61K31/4178 , A61K31/65 , A61K45/06 , A61P31/18 , C07C311/17 , C07D213/30 , C07D213/40 , C07D213/78 , C07D233/32 , C07D233/72 , C07D277/28 , C07D277/46 , C07D277/48 , C07D307/20 , C07D307/42 , C07D401/06 , C07D403/06 , C07D403/10 , C07D405/06 , C07D405/10 , C07D409/06 , C07D417/14 , C07D471/04 , C07D493/04
Abstract: Un compuesto que tiene la fórmula (V)**Fórmula** o una forma de sal farmacéuticamente aceptable, estereoisómero, éster, sal de un éster, o combinación de éstos, enel que X es O, S o NH; Y es O, S o NH; R es alquilo, alquenilo, cicloalquilo, cicloalquenilo, cicloalquilalquilo, cicloalquenilalquilo, arilalquilo o heteroarilalquilo;en el que cada R está sustituido con 0, 1 ó 2 sustituyentes seleccionados del grupo que consiste en alquilo,alquenilo, alquinilo, ciano, halo, formilo, nitro, hidroxi, alcoxi, -NH2, -N(H)alquilo, -N(alquilo)2, -C(>=O)OH,-C(>=O)Oalquilo, haloalquilo, hidroxialquilo y alcoxialquilo; R1 es ORa, -OSO2Ra, -OSO3Ra, -OPO3Ra, -OC(>=O)C(H)(R1a)NRaRb o -OC(>=O)C(H)(R1a)N(H)C(O)ORa;R1a es hidrógeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroarilo oheteroarilalquilo; en el que cada R1a está sustituido con 0, 1 ó 2 sustituyentes seleccionados independientemente delgrupo que consiste en halo, alquilo, alquenilo, alquinilo, -ORa, -SRa, -SORa, -SO2Ra, -SO2NRaRb, -C(>=O)Ra, -NRaRb,-N(Rb)C(>=O)Ra, -N(Rb)C(>=O)ORa, -N(Rb)SO2Ra, -N(Ra)SO2NRaRb, -N(Rb)C(>=NH)NRaRb, -N(Rb)C(>=O)NRaRb,-C(>=O)NRaRb y -C(>=O)ORa; R2 es H; R3 es alquilo, haloalquilo, alquenilo, haloalquenilo, alquinilo, haloalquinilo, cicloalquilo, cicloalquenilo,cicloalquenilalquilo, cicloalquilalquilo, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, arilo, arilalquilo,hidroxialquilo, alcoxialquilo, haloalcoxialquilo, -alquiloSRa, -alquiloSORa, -alquiloSO2Ra, -alquiloNRaRb,-alquiloN(Rb)C(>=O)ORa, -alquiloN(Rb)C(>=O)Ra, -alquiloN(Rb)SO2Ra o -alquiloN(Rb)SO2NRaRb; en el que cada uno delos restos cicloalquilo, cicloalquenilo, arilo, heteroarilo, heterociclo, cicloalquilo del cicloalquilalquilo, restocicloalquenilo del cicloalquenilalquilo, resto heterociclo del heterocicloalquilo, resto heteroarilo del heteroarilalquilo,resto arilo del arilalquilo está sustituido independientemente con 0, 1, 2 ó 3 sustituyentes seleccionadosindependientemente del grupo que consiste en halo, nitro, ciano, formilo, alquilo, alquenilo, alquinilo, hidroxi, alcoxi,-SH, -S(alquilo), -SO2(alquilo), -NH2, -N(H)(alquilo), - N(alquilo)2, -N(H)C(>=O)alquilo, -N(alquilo)C(>=O)alquilo,-C(>=O)OH, -C(>=O)O(alquilo), -C(>=O)NH2, -C(>=O)N(H)(alquilo), -C(>=O)N(alquilo)2, -C(>=O)alquilo, haloalquilo,hidroxialquilo, alcoxialquilo, cianoalquilo, formilalquilo, nitroalquilo, -alquiloSH, -alquiloS(alquilo), -alquiloSO2(alquilo),-alquiloNH2, -alquiloN(H)(alquilo), -alquiloN(alquilo)2, -alquiloN(H)C(>=O)alquilo, -alquiloN(alquilo)C(>=O)alquilo,-alquiloC(>=O)OH, -alquiloC(>=O)O(alquilo), -alquiloC(>=O)NH2, -alquiloC(>=O)N(H)(alquilo), -alquiloC(>=O)N(alquilo)2,-alquiloC(>=O)alquilo y R3a.
-
公开(公告)号:CA2562189C
公开(公告)日:2012-12-04
申请号:CA2562189
申请日:2005-04-06
Applicant: ABBOTT LAB
Inventor: ZHAO CHEN , SUN MINGHUA , COWART MARLON D , BENNANI YOUSSEF L
Abstract: Azacyclosteroid histamine-3 receptor ligands, pharmaceutical compositions comprising such compounds, and methods for using such compounds and compositions are described herein.
-
39.
公开(公告)号:ES2378197T3
公开(公告)日:2012-04-09
申请号:ES06814914
申请日:2006-09-19
Applicant: ABBOTT LAB
Inventor: COWART MARLON , SUN MINGHUA , ZHAO CHEN , ZHENG GUO ZHU
IPC: C07D417/04 , A61K31/428 , A61K51/04 , A61P9/10 , C07D277/64 , C07D417/08 , C07D417/12 , C07D487/04
Abstract: Un compuesto de formula: o una de sus sales farmacéuticamente aceptables o formas radiomarcadas, donde: mes0º1; uno de R1 yR2 es hidrógeno, acilo, aciloxi, alquenilo, alcoxi, alcoxialcoxi, alcoxialquilo, alcoxicarbonilo, alcoxiimino, alcoxisulfonilo, alquilo, alquilcarbonilo, alquilsulfonilo, alquinilo, amido, carboxi, ciano, cicloalquilo, fluoroalcoxi, haloalcoxi, haloalquilo, halógeno, hidroxi, hidroxialquilo, mercapto, nitro, alquiltio, -NRARB, (NRARB) carbonilo, -SO2N (R14a) (R14b), -N (R14a) SO2 (R14b), un grupo de fórmula -L2-R6, o un grupo de fórmula -L3a-R6a-L3b-Rab; el otro de R1 yR2 se selecciona del grupo que consiste en hidrógeno, ciano, halógeno, alquilo, cicloalquilo, fluoroalquilo, alcoxi, alcoxialquilo, fluoroalcoxi, alquiltio, -SO2N (R14a) (R14b), y -N (R14a) SO2 (R14b); R3a yR3b se seleccionan cada uno independientemente del grupo que consiste en hidrógeno, ciano, halógeno; alquilo, cicloalquilo, fluoroalquilo, alcoxi, alcoxialquilo, fluoroalcoxi, alquiltio, -SO2N (R14a) (R14b), y -N (R14a) SO2 (R14b); R4 yR5 se seleccionan cada uno independientemente del grupo que consiste en alquilo, fluoroalquilo, hidroxialquilo, alcoxialquilo, y cicloalquilo;o R4 y R5 tomados junto con el átomo de nitrógeno al que están anclados forman un anillo aromático; R6 es arilo, heterociclo o heterocicloalquilo; R6a es arilo o heterociclo;R6b es arilo o heterociclo;L es un enlace o alquileno; L2 es un enlace, -O-, alquileno, -C (=O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2-, -C (O) N (R14a) -, -N (R14a) C (O) -, o -N (R15) -;L3a yL3b se seleccionan cada uno independientemente del grupo que consiste en un enlace, -O-, alquileno, -C (=O) -, -S-, -SO2N (R14a) -, -N (R14a) SO2--, -C (O) N (R14a) -, -N (R14a) C (O) -, y -N (R15) -;R10 se selecciona del grupo que consiste en hidrógeno, ciano, fluoro, hidroxi, y alquilo; R14a yR14b se seleccionan cada uno independientemente en cada aparición del grupo que consiste en hidrógeno, alquilo, y cicloalquilo; R se selecciona del grupo que consiste en hidrógeno, alquilo, acilo, alcoxicarbonilo, y (R14a) (R14b) NC (O) -;y RA y RB se seleccionan independientemente entre hidrógeno, alquilo, acilo, haloalquilo, alcoxicarbonilo, cicloalquilo, y formilo.
-
公开(公告)号:BRPI0616146A2
公开(公告)日:2011-06-07
申请号:BRPI0616146
申请日:2006-09-19
Applicant: ABBOTT LAB
Inventor: COWART MARLON D , SUN MINGHUA , ZHAO CHEN , ZHENG GUO ZHU
IPC: C07D417/04 , A61K31/428 , A61K51/04 , A61P9/10 , C07D277/64 , C07D417/08 , C07D417/12 , C07D487/04
Abstract: Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
-
-
-
-
-
-
-
-
-